Literature DB >> 12676263

Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV).

Mayumi Higa1, Takao Kinjo, Kazuya Kamiyama, Katsuni Chinen, Teruo Iwamasa, Akira Arasaki, Hajime Sunakawa.   

Abstract

Up to now, many authors have reported on the EBV infection and its carcinogenic importance in undifferentiated nasopharyngeal carcinoma (WHO classification, type III), but the infection of the virus in well differentiated oral squamous cell carcinoma has not been well described. We introduce the EBV-related well differentiated oral squamous cell carcinomas in Okinawa, a subtropical island in the southernmost part of Japan. This study aimed to clarify the pathogenesis of this malignancy in this area by carrying out analysis of the histology and the Epstein-Barr (EBV) and human papillomavirus (HPV) infection. In the Department of Oral Surgery, Ryukyu University Hospital Okinawa, 188 cases of oral malignant tumours were encountered from 1996 to 2000. The histopathological examination and the sequence analysis of LMP-1 carboxy terminal region and EBNA2 region of EBV were carried out, as were the analysis of virus subtypes, A and B, BamHI-F and f, and C and D. Additionally, HPV infection in the squamous cell carcinomas were demonstrated using E6 and E7 region primer sets by PCR method. In Okinawa, 94% (177/188) of the cases were squamous cell carcinomas. A surprisingly large number of EBV (72%) and HPV (78%) infections in the oral squamous cell carcinomas were demonstrated. EBV type B virus infection was found in 36% of EBV-related oral squamous cell carcinoma in Okinawa, but in only 2-5% of the mainland cases. In both regions the incidence of the BamHI- f variant infection was very low. The infected virus in 79 out of 80 (39 Okinawan and 41 mainland) cases was BamHI- F type. In Okinawa, the numbers of C and D variants were almost equal, whereas in the mainland the D variant was rare. Further, a 30 bp deletion in LMP-1 gene was frequently demonstrated in Okinawan and mainland cases of type A virus, but not in type B virus. Lastly, single nucleotide mutations in EBNA2 region of type A virus when compared with B95-8 strain were demonstrated in Okinawan cases. The prognosis for (mostly EBV/HPV infected) squamous cell carcinomas in Okinawa was better than that in the mainland where most cases were negative for EBV and/or HPV. Copyright 2003 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676263     DOI: 10.1016/s1368-8375(02)00164-1

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  Simultaneous occurrence of Epstein-Barr virus (EBV) in periodontal pockets and in oral squamous cell carcinoma: a cross-sectional study.

Authors:  Humberto Jácome-Santos; Naira da Silva E Silva; Renata Gonçalves Resende; Helder Henrique Costa Pinheiro; Luiz Fernando Almeida Machado; Guilherme de Souza Silva; Fernando de Oliveira Costa; Igor Brasil-Costa; Ana Cláudia Braga Amoras-Alves; Ricardo Alves Mesquita; Sérgio de Melo Alves-Junior
Journal:  Clin Oral Investig       Date:  2021-11-16       Impact factor: 3.573

2.  Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1.

Authors:  Daniel J Liebertz; Melissa G Lechner; Rizwan Masood; Uttam K Sinha; Jing Han; Raj K Puri; Adrian J Correa; Alan L Epstein
Journal:  Head Neck Oncol       Date:  2010-02-22

3.  Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.

Authors:  Tetsuya Shimabuku; Ayumi Tamanaha; Bunta Kitamura; Yasuka Tanabe; Natsumi Tawata; Fukino Ikehara; Kazunari Arakaki; Takao Kinjo
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Detection of Epstein-Barr virus genome and latent infection gene expression in normal epithelia, epithelial dysplasia, and squamous cell carcinoma of the oral cavity.

Authors:  Kentaro Kikuchi; Yoshihiro Noguchi; Michelle Wendoline Garcia-Niño de Rivera; Miyako Hoshino; Hideaki Sakashita; Tsutomu Yamada; Harumi Inoue; Yuji Miyazaki; Tadashige Nozaki; Blanca Silvia González-López; Fumio Ide; Kaoru Kusama
Journal:  Tumour Biol       Date:  2015-10-08

5.  HPV involvement in OSCC: Correlation of PCR results with light microscopic features.

Authors:  Rajbir Kaur Khangura; Shamindra Sengupta; Keya Sircar; Bhudev Sharma; Sanjeet Singh; Varun Rastogi
Journal:  J Oral Maxillofac Pathol       Date:  2013-05

6.  No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.

Authors:  Torben Wilms; Gulfaraz Khan; Philip J Coates; Nicola Sgaramella; Robin Fåhraeus; Asma Hassani; Pretty S Philip; Lena Norberg Spaak; Luigi Califano; Giuseppe Colella; Katarina Olofsson; Christos Loizou; Renato Franco; Karin Nylander
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

7.  Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas.

Authors:  Aaro Turunen; Jaana Rautava; Reidar Grénman; Kari Syrjänen; Stina Syrjänen
Journal:  Oncotarget       Date:  2017-04-18

8.  Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis.

Authors:  Ching-Yu Yen; Min-Chi Lu; Ching-Cherng Tzeng; Jia-Yan Huang; Hsueh-Wei Chang; Ruey-Shyang Chen; Shyun-Yeu Liu; Shih-Tung Liu; Biehuoy Shieh; Ching Li
Journal:  J Biomed Biotechnol       Date:  2009

Review 9.  Liaison between micro-organisms and oral cancer.

Authors:  Vijayan Srinivasprasad; Janardhanam Dineshshankar; J Sathiyajeeva; M Karthikeyan; J Sunitha; Ramachandran Ragunathan
Journal:  J Pharm Bioallied Sci       Date:  2015-08

Review 10.  Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.

Authors:  Kentaro Kikuchi; Harumi Inoue; Yuji Miyazaki; Fumio Ide; Masaru Kojima; Kaoru Kusama
Journal:  Jpn Dent Sci Rev       Date:  2017-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.